NeuroBo Pharmaceuticals Reports Positive Pre-Clinical Safety

NeuroBo Pharmaceuticals Reports Positive Pre-Clinical Safety Data of DA-1241 in Combination with Sitagliptin and Opens Enrollment for Part 2 of Its Phase 2a Clinical Trial Evaluating DA-1241 for the Treatment of MASH

NeuroBo Pharmaceuticals Reports Positive Pre-Clinical Safety Data of DA-1241 in Combination with Sitagliptin and Opens Enrollment for Part 2 of Its Phase 2a Clinical Trial Evaluating DA-1241 for the Treatment of MASH

marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Cambridge , Cambridgeshire , United Kingdom , Marshallh Woodworth , Michael Miller , Nasdaq , Prnewswire Neurobo Pharmaceuticals Inc , Drug Administration , Neurobo Pharmaceuticals Inc , Donga St Co , Rx Communications Group , Neurobo Pharmaceuticals , Full Data Readout Expected , Second Half , G Protein Coupled Receptor , Hyung Heon Kim , Chief Executive Officer , Metabolic Dysfunction Associated Steatohepatitis , Private Securities Litigation Reform Act ,